Furthermore, when osteosarcoma mice were injected with MSCs and Saos-2 cells, the inhibition of STAT3 improved survival by suppressing tumour growth and increasing their susceptibility to doxorubicin. This evidence concerns the gene STAT3 and neoplasm.